☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

☐ TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☐☒ No ☒☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of ~~May 20,~~August 19, 2022, the number of shares outstanding of the registrant’s class of common stock was 27,058,338, par value of $0.001 per share.

		March 31, 2022			December 31, 2021				June 30, 2022			December 31, 2021
		(Unaudited)			(audited)				(Unaudited)			(Audited)
ASSETS	ASSETS							ASSETS
CURRENT ASSETS
Cash		$	5,988		$	5,627			$	16,314		$	5,627
Restricted cash			5,900			5,900				5,900			5,900
Inventory			58,936			56,936
Merchant cash advances, net of allowance $132,663 and $131,703, respectively			36,900			37,541
Inventory, net of reserve $23,625 and $0, respectively										33,590			56,936
Merchant cash advances, net of allowance $173,088 and $131,703, respectively										722			37,541
Prepaid expenses and other current assets			90,174			89,888				83,405			89,888
TOTAL CURRENT ASSETS			197,898			195,892				139,931			195,892

Property and equipment, net			128,594			139,103				25,232			139,103
Operating lease right-of-use assets			160,363			177,062				143,175			177,062
TOTAL ASSETS		$	486,855		$	512,057			$	308,338		$	512,057
LIABILITIES AND DEFICIT	LIABILITIES AND DEFICIT							LIABILITIES AND DEFICIT
CURRENT LIABILITIES
Accounts payable and accrued liabilities		$	1,238,123		$	1,074,216			$	1,412,184		$	1,074,216
Accounts payable and accrued liabilities - related parties			794,556			718,114				862,747			718,114
Put liability			29,421			29,421				29,421			29,421
Deferred revenue			82,089			81,953				50,746			81,953
Loans, net of unamortized debt discount			1,325,244			1,288,586				1,363,988			1,288,586
Related party loans, net of unamortized debt discount			574,021			471,009				708,313			471,009
Operating lease liabilities			71,816			69,078				74,650			69,078
TOTAL CURRENT LIABILITIES			4,115,270			3,732,377				4,502,049			3,732,377

Loans - long term			150,000			150,000				150,000			150,000
Operating lease liabilities - long term			91,154			109,975				71,323			109,975
TOTAL LIABILITIES			4,356,424			3,992,352				4,723,372			3,992,352

Commitments
Commitments (Note 8)

DEFICIT
FIRST FOODS GROUP, INC. DEFICIT:
Preferred stock, 20,000,000 shares authorized:
Series A convertible preferred stock: $0.001 par value, 1 share authorized, 1 issued and outstanding ($577,005 liquidation preference)			0			0				0			0
Series B convertible preferred stock: $0.001 par value, 4,999,999 shares authorized, 354,999 issued and outstanding, respectively ($118,235 liquidation preference)			355			355				355			355
Series C convertible preferred stock: $0.001 par value, 3,000,000 shares authorized, 660,000 shares issued and outstanding ($165,000 liquidation preference)			660			660				660			660
Common stock: $0.001 par value,100,000,000 shares authorized, 27,058,338 and 26,998,338 shares issued and outstanding, respectively			27,058			26,998
Common stock: $0.001 par value, 100,000,000 shares authorized, 27,058,338 and 26,998,338 shares issued and outstanding, respectively										27,058			26,998
Additional paid-in capital			12,174,631			12,062,341				11,894,629			12,062,341
Accumulated deficit			(15,815,410	)		(15,335,458	)			(16,051,407	)		(15,335,458	)
Total First Foods Group, Inc. Deficit			(3,612,706	)		(3,245,104	)			(4,128,705	)		(3,245,104	)

Noncontrolling interests			(256,863	)		(235,191	)			(286,329	)		(235,191	)
Total deficit			(3,869,569	)		(3,480,295	)			(4,415,034	)		(3,480,295	)
TOTAL LIABILITIES AND DEFICIT		$	486,855		$	512,057			$	308,338		$	512,057

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

	For the Three Months Ended March 31,						For the Three Months Ended June 30,						For the Six Months Ended June 30,
	2022			2021			2022			2021			2022			2021

REVENUES
Product sales, net	$	14,457		$	16,025		$	63,877		$	240,439		$	78,334		$	256,464
Merchant cash advance income, net		348			26,313			29			7,102			377			33,415
Total Revenues		14,805			42,338			63,906			247,541			78,711			289,879

OPERATING EXPENSES
Cost of product sales		2,481			3,741			37,993			162,343			40,474			166,084
Legal fees		1,149			999			27,949			2,097			29,098			3,096
General and administrative		404,485			487,387			335,492			446,423			739,978			933,810
Provision for merchant cash advances		(346	)		(137,498	)		37,145			(6,840	)		36,799			(144,338	)
Impairment of assets								92,736			0			92,736			0
Total Operating Expenses		407,769			354,629			531,315			604,023			939,085			958,652

LOSS FROM OPERATIONS		(392,964	)		(312,291	)		(467,409	)		(356,482	)		(860,374	)		(668,773	)

OTHER INCOME (EXPENSE)
Other income								291,482			0			291,482			0
Loss on extinguishment of loans payable								0			(299,773	)		0			(299,773	)
Interest expense		(108,660	)		(185,489	)		(89,536	)		(174,461	)		(198,196	)		(359,950	)

Loss before income taxes		(501,624	)		(497,780	)		(265,463	)		(830,716	)		(767,088	)		(1,328,496	)

Provision for income taxes		0			0			0			0			0			0

NET LOSS		(501,624	)		(497,780	)		(265,463	)		(830,716	)		(767,088	)		(1,328,496	)

Non-controlling interest share of loss		21,672			26,307			29,466			10,748			51,138			37,055
Deemed dividends								0			(139,690	)		0			(139,690	)

Net loss attributed to shareholders of First Foods Group, Inc.	$	(479,952	)	$	(471,473	)	$	(235,997	)	$	(959,658	)	$	(715,950	)	$	(1,431,131	)

BASIC AND DILUTED LOSS PER COMMON SHARE ATTRIBUTABLE TO FIRST FOODS GROUP, INC. STOCKHOLDERS	$	(0.02	)	$	(0.02	)	$	(0.01	)	$	(0.04	)	$	(0.03	)	$	(0.06	)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING ATTRIBUTABLE TO FIRST FOODS GROUP, INC. STOCKHOLDERS - BASIC AND DILUTED		27,342,986			22,619,887			27,058,338			24,167,311			27,050,426			23,397,874

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

First Foods Group, Inc. and Subsidiary																							First Foods Group, Inc. and Subsidiary
Condensed Consolidated Statements of Changes in Deficit																							Condensed Consolidated Statements of Changes in Deficit
(Unaudited)																							(Unaudited)
	Preferred Stock				Common Stock				Additional paid-in		Accumulated			Total First Foods Group,			Non-controlling			Total				Preferred Stock				Common Stock				Additional paid-in			Accumulated			Total First Foods Group,			Non-controlling			Total
	Shares		Amount		Shares		Amount		capital		deficit			Inc. deficit			interests			deficit				Shares		Amount		Shares		Amount		capital			deficit			Inc. deficit			interests			deficit

Balance at December 31, 2020		1,133,333		1,133		22,367,179		22,367		10,515,601		(12,954,696	)		(2,415,595	)		(142,780	)		(2,558,375	)			1,133,333	$	1,133		22,367,179	$	22,367	$	10,515,601		$	(12,954,696	)	$	(2,415,595	)	$	(142,780	)	$	(2,558,375	)
Common stock issued for cash to a related party		-		0		249,999		250		49,750		0			50,000			0			50,000				-		0		249,999		250		49,750			0			50,000			0			50,000
Common stock issued to consultants for services		-		0		36,765		37		4,963		0			5,000			0			5,000				-		0		36,765		37		4,963			0			5,000			0			5,000
Common stock issued for related party loan		-		0		140,000		140		28,520		0			28,660			0			28,660				-		0		140,000		140		28,520			0			28,660			0			28,660
Common stock issued with loans payable		-		0		18,000		18		4,662		0			4,680			0			4,680				-		0		18,000		18		4,662			0			4,680			0			4,680
Stock based compensation		-		0		-		0		65,542		0			65,542			0			65,542				-		0		-		0		65,542			0			65,542			0			65,542
Warrants issued for director services		-		0		-		0		43,693		0			43,693			0			43,693				-		0		-		0		43,693			0			43,693			0			43,693
Net loss		-		0		-		0		0		(471,473	)		(471,473	)		(26,307	)		(497,780	)			-		0		-		0		0			(471,473	)		(471,473	)		(26,307	)		(497,780	)
Balance at March 31, 2021		1,133,333		1,133		22,811,943		22,812		10,712,731		(13,426,169	)		(2,689,493	)		(169,087	)		(2,858,580	)			1,133,333		1,133		22,811,943		22,812		10,712,731			(13,426,169	)		(2,689,493	)		(169,087	)		(2,858,580	)

Common stock issued for cash to a related party																									-		0		249,999		250		49,750			0			50,000			0			50,000
Common stock issued to consultants for services - put liability																									-		0		112,390		0		0			0			0			0			0
Common stock issued for related party loan																									-		0		50,000		50		10,450			0			10,500			0			10,500
Common stock issued for conversion of loans payable																									-		0		191,424		192		31,067			0			31,259			0			31,259
Common stock issued for conversion of loans payable - related party																									-		0		2,000,000		2,000		458,000			0			460,000			0			460,000
Stock based compensation																									-		0		-		0		74,253			0			74,253			0			74,253
Warrants issued for director services																									-		0		-		0		44,179			0			44,179			0			44,179
Warrants issued for related party loan																									-		0		-		0		20,200			0			20,200			0			20,200
Warrants issued for conversion of loan payable																									-		0		-		0		83,513			0			83,513			0			83,513
Net loss																									-		0		-		0		0			(819,968	)		(819,968	)		(10,748	)		(830,716	)
Balance at June 30, 2021																									1,133,333	$	1,133		25,415,756	$	25,304	$	11,484,143		$	(14,246,137	)	$	(2,735,557	)	$	(179,835	)	$	(2,915,392	)

Balance at December 31, 2021		1,015,000		1,015		26,998,338		26,998		12,062,341		(15,335,458	)		(3,245,104	)		(235,191	)		(3,480,295	)			1,015,000	$	1,015		26,998,338	$	26,998	$	12,062,341		$	(15,335,458	)	$	(3,245,104	)	$	(235,191	)	$	(3,480,295	)
Common stock issued with loans payable		-		0		60,000		60		12,540		0			12,600			0			12,600				-		0		60,000		60		12,540			0			12,600			0			12,600
Stock based compensation		-		0		-		0		30,154		0			30,154			0			30,154				-		0		-		0		30,154			0			30,154			0			30,154
Warrants issued for director services		-		0		-		0		41,508		0			41,508			0			41,508
Warrants issued for consulting services																									-		0		-		0		41,508			0			41,508			0			41,508
Warrants issued for loan payable		-		0		-		0		28,088		0			28,088			0			28,088				-		0		-		0		28,088			0			28,088			0			28,088
Net loss		-		0		-		0		0		(479,952	)		(479,952	)		(21,672	)		(501,624	)			-		0		-		0		0			(479,952	)		(479,952	)		(21,672	)		(501,624	)
Balance at March 31, 2022		1,015,000		1,015		27,058,338		27,058		12,174,631		(15,815,410	)		(3,612,706	)		(256,863	)		(3,869,569	)			1,015,000		1,015		27,058,338		27,058		12,174,631			(15,815,410	)		(3,612,706	)		(256,863	)		(3,869,569	)

Stock based compensation																									-		0		-		0		11,480			0			11,480			0			11,480
Accumulated catch up adjustment																									-		0		-		0		(291,482	)		0			(291,482	)		0			(291,482	)
Net loss																									-		0		-		0		0			(235,997	)		(235,997	)		(29,466	)		(265,463	)
Balance at June 30, 2022																									1,015,000	$	1,015		27,058,338	$	27,058	$	11,894,629		$	(16,051,407	)	$	(4,128,705	)	$	(286,329	)	$	(4,415,034	)

	For the Three Months Ended March 31,						For the Six Months Ended June 30,
	2022			2021			2022			2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Loss	$	(501,624	)	$	(497,780	)
Net loss							$	(767,088	)	$	(1,328,496	)
Adjustments to reconcile net loss to net cash used in operating activities:
Non-employee stock based compensation		0			5,000			0			5,000
Employee stock based compensation		71,662			109,235			83,142			227,666
Accumulative catch up adjustment								(291,482	)		0
Loss on extinguishment of loans payable								0			299,773
Impairment of asset								92,736			0
Amortization of debt discount		62,857			130,051			105,394			253,549
Depreciation and amortization expense		10,510			12,798			31,108			28,566
Change in merchant allowance		961			(138,458	)		41,385			(143,986	)
Merchant cash advance direct write off		0			960			0			(1,312	)
Non-cash lease expense		16,699			14,873			33,887			30,193
Put liability								0			23,490
Inventory reserve								23,625			0
Changes in operating assets and liabilities:
Accounts receivable								0			(23,654	)
Inventory		(2,000	)		(2,929	)		(279	)		(9,373	)
Merchant cash advances		(320	)		189,396			(4,566	)		212,502
Prepaid expenses and other current assets		(286	)		35,197			(3,489	)		30,783
Vendor deposits		-			(62,430	)
Operating lease liabilities		(16,083	)		(14,769	)		(33,080	)		(29,643	)
Accounts payable and accrued liabilities		163,907			193,431			337,968			231,881
Accounts payable and accrued liabilities - related party		76,442			0
Accounts payable and accrued liabilities – related party								144,633			142,784
Deferred revenue		136			(7,702	)		(31,207	)		(14,221	)
Net cash used in operating activities		(117,139	)		(33,127	)		(237,313	)		(64,498	)

CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of equipment								0			(877	)
Net cash used in investing activities								0			(877	)

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from sale of common stock - related party		0			50,000
Proceeds from sale of common stock – related party								0			100,000
Proceeds from loans		30,000			0			30,000			103,601
Repayment of loans		0			(13,375	)		0			(33,429	)
Proceeds from related party loans		87,500			62,250			218,000			112,500
Repayments of related party loans		0			(74,411	)		0			(75,411	)
Net cash provided by financing activities		117,500			24,464			248,000			207,261

NET INCREASE (DECREASE) IN CASH AND RESTRICTED CASH		361			(8,663	)
NET INCREASE IN CASH AND RESTRICTED CASH								10,687			141,886
CASH AND RESTRICTED CASH AT BEGINNING OF THE PERIOD		11,527			50,386			11,527			50,386
CASH AND RESTRICTED CASH AT END OF THE PERIOD	$	11,888		$	41,723		$	22,214		$	192,272

CASH AND RESTRICTED CASH CONSIST OF THE FOLLOWING:
END OF THE PERIOD
Cash		5,988			41,723		$	16,314		$	168,782
Restricted Cash		5,900			0			5,900			23,490
	$	11,888		$	41,723		$	22,214		$	192,272
SUPPLEMENTAL CASH FLOW INFORMATION:
NON-CASH FINANCING ACTIVITIES:
Common stock issued with loans	$	12,600		$	4,680		$	12,600		$	4,680
Common stock issued with related party loans	$	0		$	28,660		$	0		$	59,360
Warrants issued with loans	$	28,088		$	0
Common stock and warrants issued for conversion of loan payable							$	0		$	250,000
Common stock issued for conversion of loan payable							$	0		$	25,000
$Warrants issued with loans							$	28,088		$	0

CASH PAID FOR:
Interest	$	3,130		$	45,191		$	5,052		$	83,034
Income taxes	$	0		$	0		$	0		$	0

NOTE 1 – BUSINESS SUMMARY OF SIGNIFICANT ACCOUNTING PRINCIPLES AND LIQUIDITY

First Foods Group, Inc. (the “Company” or “First Foods”) is a smaller reporting company focused on developing its specialty chocolate product line through its Holy Cacao subsidiary and participating in merchant cash advances (“MCAs”) through its 1^st Foods Funding Division. First Foods continues to pursue new brands and concepts, including the wholesaling of various health-related ~~products.~~products through its FFGI Wholesale Division.

Holy Cacao is a majority owned subsidiary that is dedicated to producing, packaging, distributing and selling specialty chocolate products, including specialty chocolate products infused with a hemp-based ingredient in accordance with the Company’s understanding of the Agricultural Act of 2014 (the “2014 Farm Bill”) and/or the Agriculture Improvement Act of 2018 (the “2018 Farm Bill,” and together with the 2014 Farm Bill, collectively, the “Farm Bill”), which renders the production of hemp in compliance with the provisions of the Farm Bill federally lawful. The Company has not been, is not, and has no current plans to be involved in producing, packaging, distributing or selling any product that is infused with a still-illegal marijuana-based ingredient THQ, although it intends to revisit the matter as regulations change in jurisdictions in which it operates.

The Company is also dedicated to licensing its intellectual property (“IP”), including its name, brand, and packaging, to third parties. The Company may license its IP to third parties that may produce, package, and distribute hemp-based products pursuant with the Company’s understanding of the Farm Bill. The Company may license its IP to third parties that may produce, package, and distribute marijuana-based products, but only as such licensing is legal. Holy Cacao holds four trademarks for the brands, “The Edibles Cult”, “Purely Irresistible”, “Mystere” and “Southeast Edibles”.

The Company also has a contract with TIER Merchant Advances LLC (“TIER”) to participate in the purchase of future receivables from qualified TIER merchants for the purpose of generating revenue for the Company. The Company also provides cash advances directly to merchants.

The accompanying unaudited condensed consolidated financial statements (“financial statements”) have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) and have been consistently applied. Certain information and footnote disclosures normally included in financial statements presented in accordance with GAAP, but which are not required for interim reporting purposes, have been omitted. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary to present fairly the financial position as of ~~March 31,~~June 30, 2022 and the results of operations and cash flows for the interim periods ended ~~March 31,~~June 30, 2022 and 2021, have been included. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended December 31, 2021 included in the Company’s Annual Report on Form 10-K, as filed with the Securities and Exchange Commission on April 14, 2022. Operating results for the three and six months ended ~~March 31,~~June 30, 2022 are not necessarily indicative of the results that may be expected for the full year ending December 31, 2022.

Long-lived assets are comprised of property and equipment. The Company evaluates its long-lived assets for impairment whenever events or changes in circumstances indicate the carrying value of an asset or group of assets may not be recoverable. If these circumstances exist, recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset group to future undiscounted net cash flows expected to be generated by the asset group. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. During the six months ended June 30, 2022 and the year ended December 31, 2021, the Company impaired property and equipment for a total of $92,736 and $46,368, respectively.

The Company’s unaudited condensed consolidated financial statements are prepared using generally accepted accounting principles in the United States of America (“GAAP”) applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has not yet established an ongoing source of revenues sufficient to cover its operating costs and allow it to continue as a going concern. The ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it becomes profitable. If the Company is unable to obtain adequate capital, it could be forced to cease operations. These factors raise substantial doubt regarding the Company’s ability to continue as a going concern for the next 12 months following the issuance of these unaudited condensed consolidated financial statements.

In order to continue as a going concern, the Company will need, among other things, additional capital resources. As of ~~March 31,~~June 30, 2022, the Company had approximately ~~$1,367,000~~$1,364,000 in third-party short-term debt and approximately ~~$42,000~~$3,100 in associated debt discount and approximately ~~$578,000~~$708,000 in related-party short-term debt and ~~approximately $3,800~~$0 in associated debt discount that is due within the next twelve months. Management’s plan is to increase revenue, obtain such resources for the Company by obtaining capital from management and significant shareholders sufficient to meet its operating expenses and seeking equity and/or debt financing. However, neither any members of management nor any significant shareholders are currently committed to invest funds with us and, therefore, we cannot provide any assurances that the Company will be successful in accomplishing any of its plans.

The Company does not have sufficient cash flow for the next twelve months from the date of this report. The ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plans described in the preceding paragraph and eventually secure other sources of financing and attain profitable operations. The accompanying unaudited condensed consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies. Unless otherwise discussed, the Company believes that the impact of recently issued standards that are not yet effective will not have a material impact on its consolidated financial position or results of operations upon adoption.

In June 2016, the FASB issued ASU 2016-13, “Financial Instruments – Credit Losses” to improve information on credit losses for financial assets and net investment in leases that are not accounted for at fair value through net income. ASU 2016-13 replaces the current incurred loss impairment methodology with a methodology that reflects expected credit losses. In April 2019 and May 2019, the FASB issued ASU No. 2019-04, ”Codification Improvements to Topic 326, Financial Instruments-Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments” and ASU No. 2019-05, ”Financial Instruments-Credit Losses (Topic 326): Targeted Transition Relief” which provided additional implementation guidance on the previously issued ASU. In November 2019, the FASB issued ASU 2019-10, “Financial Instruments - Credit Loss (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842),” which defers the effective date for public filers that are considered small reporting companies (“SRC”) as defined by the Securities and Exchange Commission to fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. Since the Company is an SRC, implementation is not needed until January 1, 2023. The Company will continue to evaluate the effect adopting ASU 2016-13 will have on the Company’s consolidated financial statements.

In May 2021, the FASB issued ASU 2021-04, “Earnings Per Share (Topic 260),– Debt - Modifications and Extinguishments (Subtopic 470-50), Compensation - Stock Compensation (Topic 718), and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40): Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity – Classified Written Call Options (a consensus of the FASB Emerging Issues Task Force).” The ASU addresses how an issuer should account for modifications or an exchange of freestanding written call options classified as equity that is not within the scope of another Topic. For both public and private companies, the ASU is effective for fiscal years beginning after December 15, 2021. Transition is prospective. Early adoption is permitted. The ~~Company's~~Company’s adoption of ASU 2021-04 on January 1, 2022 did not have a material impact on its unaudited condensed consolidated financial statements.

On February 27, 2017, Harold Kestenbaum assumed the role of Chairman of the Board of Directors and Interim Chief Executive Officer (“Interim CEO”). Mr. Kestenbaum earned $40,000 per year for his role as Chairman of the Board and no longer takes compensation. As of ~~March 31,~~June 30, 2022, the Company has accrued a total of $40,000 of compensation for his role as Interim CEO under the previous agreement.

As of ~~March 31,~~June 30, 2022, the Company has a consulting agreement with R and W Financial (a company owned by a director) for $5,000 a month. The agreement is for an indefinite period of time and is subject to cancellation by either party with written notice of 30 days. The outstanding balance as of ~~March 31,~~June 30, 2022 and December 31, 2021 was ~~$162,068~~$177,960 and $146,303, respectively.

** - During the three month end periods ended March 31, 2022 and 2021, the company extended the terms of the notes identified above, the extension of the term was accounted for as a modification to the original note. The company capitalized new costs of $0 and $28,660, for the period ended March 31,

* - unsecured note

** - During the six months ended June 30, 2022 and 2021, the company extended the terms of the notes identified above. The extension of the term was accounted for as a modification to the original note. The company capitalized new costs of $0 and $59,360, for the period ended June 30, 2022 and 2021, respectively, as a result of the modifications.

During the ~~three~~six months ended ~~March 31,~~June 30, 2022 and 2021, the Company recorded ~~$15,512~~$19,304 and ~~$33,354~~$57,470 of interest expense related to the amortization of debt discount and ~~$5,918~~$11,901 and ~~$13,315~~$22,258 of regular interest, respectively.

During the three months ended June 30, 2022 and 2021, the Company recorded $3,792 and $24,116 of interest expense related to the amortization of debt discount and $5,984 and $8,942 of regular interest, respectively.

As of ~~March 31,~~June 30, 2022 and December 31, 2021, accrued interest was ~~$74,067~~$80,051 and $68,149, respectively.

During the six months ended June 30, 2021, the Company converted $250,000 of loan payable in exchange for 2,000,000 shares of common stock and warrants for the right to purchase 375,000 shares of common stock. The aggregate fair value of the common stock shares issued and for the granted warrants was $543,513. The Company recorded a loss on extinguishment of debt of $293,513.

As of ~~March 31,~~June 30, 2022 and December 31, 2021, the Company owed a Director ~~$182,488~~$204,787 and $150,822, respectively, for expenses incurred on behalf of the Company.

The Company annually revisits the board of director agreements, which include quarterly compensation of $10,000 per director for the fiscal year. Three of the five board members currently are compensated under these terms, while the other two board members remain unpaid. As of ~~March 31,~~June 30, 2022 and December 31, 2021, the Company has accrued ~~$410,000~~$440,000 and $381,000, respectively, in relation to the director agreements ~~and~~which is included in Accounts payable and accrued liabilities -– related parties on the unaudited condensed consolidated balance sheet.

On July 7, 2020, our Board of Directors appointed Michael Kaplan to the Board of Directors for a term of 2 years, who currently remains as an uncompensated board member (see note 6 for details). If terminated with cause by the Company, the consultant shall not thereafter be entitled to any form of compensation, the unvested warrants shall terminate, and he shall be paid a buyout fee in the amount of 250,000 fully vested warrants. If terminated without cause by the Company, all unvested warrants shall be accelerated and vest in one-half the time it was previously scheduled to vest.

	March 31, 2022			December 31, 2021			June 30, 2022			December 31, 2021
Leasehold improvements	$	33,000		$	33,000		$	33,000		$	33,000
Equipment		201,024			201,024			201,024			201,024
Less: Accumulated depreciation and amortization		(105,430	)		(94,921	)
Less: Accumulated depreciation, amortization and impairment								(208,792	)		(94,921	)
Total	$	128,594		$	139,103		$	25,232		$	139,103

	March 31,		December 31,		June 30,		December 31,
	2022		2021		2022		2021
Accounts Payable	$	280,872	$	221,206	$	324,323	$	221,206
Interest		254,331		209,311		299,866		209,311
Salaries		666,777		603,371		730,183		603,371
Other		36,143		40,328		57,812		40,328
Total third party payables		1,238,123		1,074,216		1,412,184		1,074,216
Related party payables, officers and director fees		794,556		718,114		862,747		718,114
Total payables	$	2,032,679	$	1,792,330	$	2,274,931	$	1,792,330

** - secured note and collateralized by all tangible and intangible personal property

**** - During the ~~three month end periods~~six months ended ~~March 31,~~June 30, 2022 and 2021, the company extended the terms of the notes identified above, the extension of the term was accounted for as a modification to the original note. The company capitalized new costs of $40,688 and $4,680, for the period ended ~~March 31,~~June 30, 2022 and 2021, respectively, as a result of the modifications.

On August 1, 2022, the Company extended the terms of Note 7 above. In connection with this extension the Company issued a warrant to purchase 60,000 shares of common stock. The warrants are valued at $7,788 based on the Black Scholes Model, are fully vested as of the issue date and have an exercise term of three (3) years. The Company ~~has experienced~~recorded a ~~shortage of funding because cash outflows in~~debt discount and will amortize it over the first quarter for business administration were higher than business revenue and financing expectations. As a result, interest payables of $117,255 on the Company’s loans with Acuity Opportunities Fund I, LLC (the “Lender”) (notes 4,5,6 and 8 in the above table) due by April, 16, 2022, April 30, 2022 and July 29, 2022 remained unpaid as of March 31, 2022. The carrying amountlife of the loans payable in default as of March 31, 2022 is $846,000. The Company’s management has successfully negotiated interest and loan extensions with the lender in prior periods and will continue to negotiate further extensions with the lender for future periods. The loan with the lender is presented as a current liability as of March 31, 2022.loan.

In connection with the various debts issuances and extensions, the Company periodically, as applicable, records debt discount and amortizes it over the applicable life of the debt. During the three months ended ~~March 31,~~June 30, 2022 and 2021, the Company recorded ~~$47,344~~$38,744 and ~~$96,697~~$99,382 of interest expense related to the amortization of debt discount and ~~$41,856~~$38,134 and ~~$41,303~~$41,687 of regular interest, respectively. During the six months ended June 30, 2022 and 2021, the Company recorded $86,090 and $196,079 of interest expense related to the amortization of debt discount and $75,848 and $82,990 of regular interest, respectively. As of ~~March 31,~~June 30, 2022 and December 31, 2021, accrued interest was ~~$170,493~~$208,627 and $132,778, respectively.

As of ~~March 31,~~June 30, 2022 and December 31, 2021, accrued interest associated with the economic injury disaster loan was ~~$9,771~~$11,188 and $8,385, respectively.

On July 7, 2020, our Board of Directors appointed Michael Kaplan to the Board of Directors. In connection with the agreement one million (1,000,000) warrants were issued. The warrants are valued at $177,200 based on the Black Scholes Model. For the ~~three~~six months ended ~~March 31,~~June 30, 2022 and 2021, the Company recorded $0 and ~~$43,693~~$87,872 as compensation expense related to the warrants, respectively. For the three months ended June 30, 2022 and 2021, the Company recorded $0 and $44,179 as compensation expense related to the warrants, respectively.

Prior to Mr. Kaplan’s appointment to the Board of Directors, on July 7, 2020 the Company entered into a Consulting Agreement with Mr. Kaplan to award him, as full compensation for two (2) years of service, warrants to purchase two million (2,000,000) shares of common stock, if certain milestones are reached, at an exercise price of $0.18 per share, which was the closing price of our common stock on such date. The warrants are valued at $354,400 based on the Black Scholes Model. ~~Due to~~When the ~~fact that~~warrants were issued management ~~has~~had assessed the probability of certain milestones being met as probable and therefore the warrants ~~are~~were being straight-lined over the term of services and accelerated whenever a milestone is met. ~~The probability~~During the quarter ending June 30, 2022, management, upon further review, has determined that these milestones will probably not be met and has recorded an accumulative catch up adjustment of $291,482. For the ~~remaining milestones being met is reviewed by management every quarter. For each of the three~~six months ended ~~March 31,~~June 30, 2022 and 2021, the Company recorded $41,508 and $83,478 as compensation expense related to the ~~warrants.~~warrants, respectively. For the three months ended June 30, 2022 and 2021, the Company recorded $0 and $41,970 as compensation expense related to the warrants, respectively. The warrants shall vest upon the occurrence to the Company of the following milestone events through the efforts of the ~~consultant:~~consultant. In July 2022, the term of the consulting agreement ended with no further milestones being completed. No further compensation will be recorded in association to these warrants:

On August 4, 2020, the Company signed an Employment Agreement for a term of three years with an annual base salary of ~~eighty four~~eighty-four thousand dollars ($84,000). As part of the agreement the Company will issue a warrant to the employee to purchase 300,000 shares a year, for a total of 900,000 shares of the Company’s common stock. The warrants have a term of three (3) years from date of issue and an exercise price equal to the closing market price of the Company’s common stock on August 4, of the corresponding year. The warrants issued on August 4, 2020, 2021 and ~~2021,~~2022, are valued at $97,470, $46,050 and ~~$46,050,~~$22,740, respectively, based on the Black Scholes Model. The warrants will be subject to a 12-month period whereby the warrants will vest in equal monthly increments for each year of the employment period. Once per quarter, the employee may waive the right to receive 25,000 warrants and receive in exchange for $5,000 worth of shares of the Company’s common stock. In the event the employee’s employment is terminated by the Company without cause, the employee shall be entitled to receive severance in an amount equal to the lesser of three month’s salary or the amount of salary otherwise payable until the termination date. The employee additionally shall be entitled to retain all warrants scheduled to vest within the following six months. For the ~~three~~six months ended ~~March 31,~~June 30, 2022 and 2021, the Company recorded ~~$30,153~~$41,634 and ~~$24,034~~$48,334 as compensation expense related to the warrants, respectively. For the three months ended June 30, 2022 and 2021, the Company recorded $11,480 and $24,301 as compensation expense related to the warrants, respectively.

On March 21, 2022, the Company extended the maturity date on one of its promissory notes (see Note 5). In association with this extension the company granted warrants for the right to purchase 125,000 shares of common stock at an exercise price of $0.24 a share. The warrants are valued at $28,088 based on the Black Scholes Model, are fully vested as of the issue date and have an exercise term of three (3) years. The Company recorded a debt discount and will amortize it over the life of the loan.

The Company utilized the Black-Scholes option-pricing model to estimate fair value, utilizing the following assumptions for the respective period:

	2022			2021			2022				2021
Risk-free interest rate		0.22	%	0.03-0.08		%		0.22	%		0.03-0.08		%
Expected term of options, in years		3			3			3				3
Expected annual volatility		214.0	%	228.0-247.7		%		214.0	%		228.0-247.7		%
Expected dividend yield	-		%	-		%	-		%		-		%
Determined grant date fair value per option	$	0.15 -0.22		$ 0.14 - 0.22			$	0.15 – 0.22		$	0.14 – 0.22

A summary of the Company’s warrants to purchase common stock activity is as follows:

	Number of Warrants (in common shares)			Weighted Average Exercise Price		Number of Warrants (in common shares)			Weighted Average Exercise Price
Outstanding, December 31, 2020		4,899,750		$	0.21		4,899,750		$	0.21
Granted		1,148,775			0.19		1,148,775			0.19
Exercised		-			0		-			0
Forfeited or cancelled		(343,750	)		0.08		(343,750	)		0.08
Outstanding, December 31, 2021		5,704,775		$	0.22		5,704,775		$	0.22
Granted		425,000			0.18		425,000			0.18
Exercised		-			0		-			0
Forfeited or cancelled		(60,000	)		0.30		(60,000	)		0.30
Outstanding, March 31, 2022		6,069,775		$	0.21
Outstanding, June 30, 2022							6,069,775		$	0.21

As of ~~March 31,~~June 30, 2022, ~~4,069,775~~4,144,775 warrants for common stock were exercisable and the intrinsic value of these warrants was ~~$184,014,~~$0, the weighted average remaining contractual life for warrants outstanding was ~~1.92~~1.67 years and the remaining expense is ~~$61,095~~$4,416 over the remaining amortization period which is ~~four~~three months.

As of ~~March 31,~~June 30, 2021, ~~2,628,917~~3,468,391 warrants for common stock were exercisable and the intrinsic value of these warrants was ~~$262,660,~~$76,742, the weighted average remaining contractual life for warrants outstanding was ~~2.56~~2.01 years and the remaining expense is ~~$294,762~~$184,313 over the remaining amortization period which is 1.25 years.

A summary of the Company’s warrants to purchase Series B Preferred Stock activity is as follows:

	Number of Warrants (in Series B Preferred Stock)		Weighted Average Exercise Price		Number of Warrants (in Series B Preferred Stock)		Weighted Average Exercise Price
Outstanding, December 31, 2020		4,470,000	$	0.68		4,470,000	$	0.68
Granted		-		0		-		0
Exercised		-		0		-		0
Forfeited or cancelled		-		0		-		0
Outstanding, December 31, 2021		4,470,000	$	0.68		4,470,000	$	0.68
Granted		-		0		-		0
Exercised		-		0		-		0
Forfeited or cancelled		-		0		-		0
Outstanding, March 31, 2022		4,470,000	$	0.68
Outstanding, June 30, 2022						4,470,000	$	0.68

As of ~~March 31,~~June 30, 2022, 4,470,000 warrants for Series B preferred stock were exercisable and the intrinsic value of these warrants was ~~$2,674,350,~~$0, the weighted average remaining contractual life for warrants outstanding was ~~6.12~~5.87 years.

As of ~~March 31,~~June 30, 2021, 4,470,000 warrants for Series B preferred stock were exercisable and the intrinsic value of these warrants was ~~$4,350,600,~~$1,739,250, the weighted average remaining contractual life for warrants outstanding was ~~7.12~~6.87 years.

On June 23, 2020, the Company entered into an operating lease agreement with a term of 4 years, and an option to extend for three years, comprising of office and warehouse space. This option is included in the lease term when it is reasonably certain that the option will be exercised and failure to exercise such option will result in economic penalty and as such the option to extend for the three-year term is not included in the below calculation.

For ~~each of~~ the ~~three~~six months ended ~~March 31,~~June 30, 2022 and 2021, the Company incurred lease expense for its operating leases of ~~$21,911,~~$43,821 and $43,821, respectively, which was included in general and administrative expenses on the accompanying unaudited condensed consolidated statements of operations.

For the three months ended June 30, 2022 and 2021, the Company incurred lease expense for its operating leases of $21,910 and $21,910, respectively, which was included in general and administrative expenses on the accompanying unaudited condensed consolidated statements of operations.

The Company’s weighted-average remaining lease term relating to its operating leases is ~~2.08~~1.83 years, with a weighted-average discount rate of 12.00%.

The Company had cash payments for operating leases of ~~$21,806~~$43,015 and $43,271 for ~~each of~~the six months ended June 30, 2022 and 2021, respectively and $21,720 and $21,465 for the three months ended ~~March 31,~~June 30, 2022 and ~~2021.~~2021, respectively.

The following table presents information about the amount, timing and uncertainty of cash flows arising from the Company’s operating leases as of ~~March 31,~~June 30, 2022.

Maturity of Lease Liability
2022	$	65,587	$	43,866
2023		89,487		89,487
2024		30,120		30,120
Total undiscounted operating lease payments		185,194		163,474
Less: Imputed interest		22,224		17,501
Present value of operating lease liabilities	$	162,970	$	145,973

On July 16, 2018, the Company entered into a consulting agreement with a service provider that contains the following terms:

On August 14, 2019, the Company entered into an agreement with a CFN Media. In consideration for the services and deliverables provided by CFN Media, the Company will make three (3) cash payments to CFN Media totaling $30,000. Payments will be made in accordance with the following staged schedule:

“Stage 1” - $10,000 due upon the signing of the agreement for the Stage 1 services and deliverables: the interview, lead generation system and two (2) articles, including syndication, distribution and placement. This payment has been made.

“Stage 2” - $10,000 due upon the Company’s receipt of CFN Media’s invoice issued after CFN Media’s completion of Stage 1 and the Company’s confirmation they are ready to continue with Stage 2, which will include CFN Media’s delivery of two (2) Articles with the embedded interview and lead generation, as well as syndication, distribution and placement of services and deliverables.

“Stage 3” - $10,000 due upon the Company’s receipt of CFN Media’s invoice issued after CFN Media’s completion of Stage 2 and the Company’s confirmation they are ready to continue with Stage 3, which will include CFN Media’s delivery of two (2) Articles with the embedded interview and lead generation, as well as syndication, distribution and placement of services and deliverables.

On October 10, 2019, the Company signed a master distribution agreement with CBD Unlimited, Inc., which is a public company and a master distributor, to distribute the Company’s hemp-based chocolate products. The term of this agreement is four years. The agreement includes the issuance of 250,000 shares of the Company’s common stock at the closing market price of $0.26 per share as of the date of the agreement. Additionally, the Company shall pay the distributor a commission for its services hereunder amounting to applicable percentage of the sales price of any sales or sales contract with a customer.

On January 14, 2020, the Company entered into an agreement with a sales consultant to further the business purpose of the Company. In consideration for the services provided by the consultant, the Consultant shall be paid a fee of ten percent (10%) of each of the consultant’s sales of the Company’s product.

On October 15, 2020, the Company entered into a chocolate sales agreement with a sales consultant. The consultant will receive a commission of the gross sales (net of returns) that were directly generated by the consultant to new customers. The consultant shall receive a sales commission of the gross sales (net of returns) directly generated by the consultant to such distributor and such distributor shall receive a commission of such gross sales (net of returns). Commissions shall be paid within 30 days of the end of the quarter in which they are deemed earned. No commissions are due and no commissions have been earned as of ~~March 31,~~June 30, 2022. In addition, once the consultant has made $75,000 of gross sales (net of returns) he shall receive 75,000 shares of the Company’s common stock. This agreement shall continue for sixty months from the date of the agreement and will automatically extend for additional successive sixty-month terms unless written notice is delivered at least thirty days prior to the end of the current term.

On November 9, 2020, the Company entered into an agreement with a consultant. The consultant shall provide the following services: develop a marketing plan and act as a sales agent with respect to the wholesale of various products by the Company. As compensation for the services, the consultant shall receive a cash payment in an amount in excess of 9% of the profit margin. However, in the event the average closing price of the Company’s common stock on the common stock’s primary market over the final ten (10) trading days of any month is greater than or equal to $0.50, then the cash compensation for such month shall only be the amount of profit margin generated by the sales of the products in excess of 14% of gross sales and the amount of profit margin between 9% and 14% of gross sales shall completely belong to the Company. Prior to the payment date of each month, the consultant can elect to receive all or part of the cash compensation due for such month in the form of common stock by providing written notice of such election to the Company. The number of shares to be issued shall be calculated based upon a per share value equal to 80% of the valuation price. This agreement shall commence on the effective date and shall continue for a term of two (2) years. Prior to six months after the effective date this agreement may not be cancelled without cause. After six months this agreement may be sooner terminated by either party upon sixty days written notice. Commencing 120 days after the effective date, absent an effective registration statement by the Company covering the shares, the sales consultant may “Put” to the Company any vested shares at a price per share equal to the grant price at any time during the term. The Company shall maintain a separate account with funds to pay for the Put for as long as the Put is exercisable and the Put right shall be subject to the terms governing such account. As of ~~March 31,~~June 30, 2022, the Company has recorded a Put liability of $29,421. The Consultant has agreed to lower the restricted cash amount for the Put to $5,900.

On November 9, 2020, the Company entered into a grant agreement with a sales consultant. As compensation for the services, the Company will issue up to three million (3,000,000) shares to the sales consultant in monthly installments over the twenty (24) month term of the agreement. The number of shares to be issued by the Company to the sales consultant on a monthly basis will be determined by the amount of net sales of various wholesale products generated by the sales consultant at the end of each month multiplied by a fixed percentage of nine percent (9%) divided by the last closing market price of the shares as of the effective date. In addition to the shares to be issued, the sales consultant shall be issued three million (3,000,000) warrants to purchase shares. One warrant shall be fully vested for every share issued. The exercise price of each warrant shall be equal to the grant price and each warrant shall be exercisable for thirty-six (36) months following the date of vesting. Until such time as the shares underlying the warrants are registered, the warrants may be exercised via a cashless exercise. As of ~~March 31,~~June 30, 2022, there were 2,852,009 shares of common stock and 2,942,725 warrants remaining to be issued if certain performance thresholds are met.

On January 14, 2021, the Company entered into an agreement with a sales consultant to further the business purpose of the Company. In consideration for the services provided by the consultant, the consultant will receive a commission of the gross sales (net of returns) that were directly generated by the consultant to new customers. This agreement shall continue for sixty months from the date of the agreement and will automatically extend for additional successive ~~sixty month~~sixty-month terms unless written notice is delivered at least thirty days prior to the end of the current term.

On January 4, 2022, the Company entered into a grant agreement with a sales consultant. As compensation for the services, the Company will issue up to 2,380,952 shares of restricted common stock to the sales consultant in monthly installments over the twenty (24) month term of the agreement. The number of shares to be issued by the Company to the sales consultant on a monthly basis will be determined by the amount of net sales of products generated by the sales consultant at the end of each month multiplied by a fixed percentage of 5% divided by the last closing market price of the shares as of the effective date. Additionally, if the sales consultant makes sales using salespeople who are not under contract with the Company, the Company will pay the consultant a cash commission at the end of each month equal to 5% of net sales over the term. During the three and six months ended June 30, 2022 no shares have been issued.

On March 2, 2022, the Company entered into two agreements with two consultants to further the business purpose of the Company. In consideration for the services provided by the consultants, the consultants will receive a 10% commission of the gross sales (net of returns) that were directly generated by the consultants to new customers. This agreement shall continue for sixty months from the date of the agreement and will automatically extend for additional successive ~~sixty month~~sixty-month terms unless written notice is delivered at least thirty days prior to the end of the current term.

On March 23, 2022, the Company entered into a grant agreement with a sales consultant. As compensation for the services, the Company will issue up to 2,083,333 shares of restricted common stock to the sales consultant in monthly installments over the twenty (24) month term of the agreement. The number of shares to be issued by the Company to the sales consultant on a monthly basis will be determined by the amount of net sales of products generated by the sales consultant at the end of each month multiplied by a fixed percentage of 5% divided by the last closing market price of the shares as of the effective date. During the three and six months ended June 30, 2022 no shares have been issued.

On April 11, 2022, the Company entered into a memo of understanding with a marketing consultant, who is a National Football League (NFL) celebrity. As compensation for the services, the Company agrees to split the net profit on a 50 / 50 basis derived from the sales of the Company’s products that will be branded under the consultant’s name and result from the marketing consultant’s efforts. The marketing consultant will be paid on a quarterly basis over the two (2) year term.

Commission costs for the ~~three~~six months ending ~~March 31,~~June 30, 2022 and 2021, were $0 and ~~$1,138,~~$34,986, respectively. Commission costs for the three months ending June 30, 2022 and 2021, were $0 and $33,848, respectively. These expenses are included in general and administrative expenses on the accompanying unaudited condensed consolidated statements of operations. As of ~~March 31,~~June 30, 2022 and December 31, 2021, there were no accrued commissions outstanding.

As of ~~March 31,~~June 30, 2022, the ~~Company's~~Company’s concentrations for receivables from merchant cash advances as well as income from merchant cash advances were not significant to warrant concentration risk.

As of December 31, 2021, the Company’s receivables from merchant cash advances included $29,290 from one merchant, representing 78% of the Company’s merchant cash ~~advances~~advances. The Company earned $14,949 and $4,287 of MCA income from ~~one merchant,~~two merchants, representing ~~57%~~45% and 13%, respectively, of the Company’s MCA income for the ~~three~~six months ended ~~March 31,~~June 30, 2021.

For the three months ended ~~March 31,~~June 30, 2022, the Company had purchase concentrations of ~~54%~~52%, 29% and ~~27%~~11% from three vendors. For the three months ended June 30, 2021, the Company had purchase concentrations of 88% from two vendors.

For the ~~three~~six months ended ~~March 31,~~June 30, 2022, the Company had purchase concentrations of 31%, 22%, 17%, 11%, and 10% from five vendors. For the six months ended June 30, 2021, the Company had purchase concentrations of ~~85%~~88% from ~~one vendor.~~two vendors.

Subsequent to the year end, the Company has extended various loans (see notes 2 and 5) and ~~has entered into~~issued 300,000 warrants to an ~~agreement with a consultant (seen~~employee (see note 8)6).

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

This Form 10-Q contains “forward-looking statements,” as that term is used in federal securities laws, about First Foods Group, Inc.’s financial condition, results of operations and business.

There is no assurance that First Foods will be profitable, due to, among other potential reasons, that it may (i) not be able to successfully develop, manage or market its products and services; attract or retain qualified executives and personnel; or obtain customers for its products or services, (ii) incur additional dilution in outstanding stock ownership due to the issuance of more shares, warrants, stock options or other convertible securities, or the exercise of outstanding warrants and stock options, and (iii) suffer other risks inherent in its business.

Because the forward-looking statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by the forward-looking statements. First Foods cautions you not to place undue reliance on the statements, which speak only of management’s plans and expectations as of the date of this Form 10-Q. The cautionary statements contained or referred to in this section should be considered in connection with any subsequent written or oral forward-looking statements that First Foods or persons acting on its behalf may issue. First Foods does not undertake any obligation to review or confirm analysts’ expectations or estimates or to release publicly any revisions to any forward-looking statements to reflect events or circumstances after the date of this Form 10-Q, or to reflect the occurrence of unanticipated events.

First Foods is currently a “smaller reporting company” under the JOBS Act. A company loses its “smaller reporting company” status on (i) the day its public float becomes greater than or equal to $250,000,000 or (ii) had annual revenues of less than $100,000,000 and either: (A) had no public float or (B) had a public float of less than $700,000,000. As a “smaller reporting company” First Foods is exempt from certain obligations of the Exchange Act, including those found in Section 14A(a) and (b) related to shareholder approval of executive compensation and golden parachute compensation and Section 404(b) of the Sarbanes-Oxley Act of 2002 related to the requirement that management assess the effectiveness of the Company’s internal control for financial reporting. Furthermore, Section 103 of the JOBS Act provides that as a “smaller reporting company” First Foods is not required to comply with the requirement to provide an auditor’s attestation of ICFR under Section 404(b) of the Sarbanes-Oxley Act for as long as First Foods qualifies as a “smaller reporting company.” In addition, a “smaller reporting company” may include less extensive narrative disclosure than required of other reporting companies, particularly in the description of executive compensation and provide audited financial statements for two fiscal years, in contrast to other reporting companies, which must provide audited financial statements for three fiscal years. However, a “smaller reporting company” is not exempt from the requirement to perform management’s assessment of internal control over financial reporting.

First Foods is focused on developing its specialty chocolate product line through its Holy Cacao subsidiary, participating in merchant cash advances (“MCAs”) through ~~its~~ it^s1st Foods Funding Division, and introducing new health-related brands, concepts and products through its FFGI Wholesaling Division.

Holy Cacao is a majority owned subsidiary that is dedicated to producing, packaging, distributing and selling specialty chocolate products, including specialty chocolate products infused with a hemp-based ingredient in accordance with the Company’s understanding of the Agricultural Act of 2014 (the “2014 Farm Bill”) and/or the Agriculture Improvement Act of 2018 (the “2018 Farm Bill,” and together with the 2014 Farm Bill, collectively, the “Farm Bill”), which renders the production of hemp in compliance with the provisions of the Farm Bill federally lawful. The Company has not been, is not, and has no current plans to be involved in producing, packaging, distributing or selling any product that is infused with a still illegal marijuana-based ingredient such as THQ, although it intends to revisit the matter asif regulations change in jurisdictions in which it operates.

The Company also has a contract with TIER Merchant Advances LLC (“TIER”) to participate in the purchase of future receivables from qualified TIER ~~merchants for the purpose of generating near-term and long-term revenue for the Company. The Company also provides cash advances directly to~~ merchants.

The Company’s principal executive offices are located at First Foods Group, Inc. c/o Incorp Services, Inc., 3773 Howard Hughes Parkway, Suite 500S, Las Vegas, NV 89169-6014. Our telephone number is (201) 471-0988.

As of ~~March 31,~~June 30, 2022, our cash balance was ~~$11,888,~~$22,214, which includes restricted cash of $5,900, and our current liabilities were ~~$4,115,270.~~$4,502,049.

Our discussion and analysis of our financial condition and results of operations are based upon our unaudited condensed consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these unaudited condensed consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. We monitor our estimates on an on-going basis for changes in facts and circumstances, and material changes in these estimates could occur in the future. Changes in estimates are recorded in the period in which they become known. We base our estimates on historical experience and other assumptions that we believe to be reasonable under the circumstances. Actual results may differ from our estimates, if past experience or other assumptions do not turn out to be substantially accurate.

Certain of our accounting policies are particularly important to the portrayal and understanding of our financial position and results of operations and require us to apply significant judgment in their application. As a result, these policies are subject to an inherent degree of uncertainty. In applying these policies, we use our judgment in making certain assumptions and estimates. Our critical accounting policies are outlined in Note 1 in the Notes to the Unaudited Condensed Consolidated Financial Statements.

Results of Operations for the Three Months Ended ~~March 31,~~June 30, 2022 compared to the Three Months Ended ~~March 31,~~June 30, 2021

Total net sales decreased ~~65%~~74% or ~~$27,533~~$183,635 during the three months ended ~~March 31,~~June 30, 2022 compared to 2021, primarily due to the Company discontinuing its wholesaling division and phasing out the merchant cash advance division to focus and ~~put~~dedicate resources to the chocolate producing division of the Company.

The following table shows net sales by category for the three months ended ~~March 31,~~June 30, 2022 and 2021:

	2022		Change			2021		2022		Change			2021
Net sales by category:
Chocolate products	$	14,457		-10	%	$	16,025	$	63,877		-73	%	$	240,439
Merchant cash advances		348		-99	%		26,313		29		-99	%		7,102
Total net sales	$	14,805		-65	%	$	42,338	$	63,906		-74	%	$	247,541

Chocolate products sales decreased ~~slightly~~ during 2022 compared to 2021 due primarily to increased supply chain ~~costs.~~costs and a decrease in marketing and advertising.

Merchant cash advances sales decreased during 2022 compared to 2021 due to the Company focusing upon and ~~placing~~dedicating resources to the chocolate producing division of the Company.

Products cost of sales for ~~March 31,~~the three months ended June 30, 2022 and 2021 were as follows:

March 31,

2022

March 31,

2021

June 30,

2022

June 30,

2021

Cost of Product Sales:

Chocolate products

2,481

3,741

37,993

162,343

The decrease in cost of product sales in ~~March 31,~~June 30, 2022 as compared to ~~March 31,~~June 30, 2021 was due to a decrease in product sales. ~~Gross profit margins increased due to better efficiencies.~~

Legal fees for the three months ended ~~March 31,~~June 30, 2022 was ~~$1,149~~$27,949 compared to ~~$999~~$2,097 for the three months ended ~~March 31,~~June 30, 2021. This ~~slight~~ increase in legal fees was due to ~~slightly~~ increased legal ~~rates.~~rates and legal consultations for potential deals that were passed on.

General and administrative expenses for the three months ended ~~March 31,~~June 30, 2022 was ~~$404,485~~$335,493 compared to ~~$487,387~~$446,423 for the three months ended ~~March 31,~~June 30, 2021. The decrease in general and administrative expenses was primarily due to decreased costs associated with compensation expenses, and consulting and accounting fees.

Provision for merchant cash advances for the three months ended June 30, 2022 was $37,145 compared to $(6,840) for the three months ended June 30, 2021. The increase in provision for merchant cash advances was due to the Company updating its reserves to accurately reflect its current merchant cash advances positions.

Impairment of assets expense for the three months ended June 30, 2022 was $92,736. The company has not realized cash flows sufficient to overcome an asset impairment and is, therefore, estimating an impairment of 50% of its asset carrying value. There was no impairment expense for the three months ended June 30, 2021.

Results of Operations for the Six Months Ended June 30, 2022 compared to the Six Months Ended June 30, 2021

Total net sales decreased 73% or $211,168 during the six months ended June 30, 2022 compared to the six months ended June 30, 2021, primarily due to the Company discontinuing its wholesaling division and phasing out the merchant cash advance division to focus and dedicate resources to the chocolate producing division of the Company.

The following table shows net sales by category for the six months ended June 30, 2022 and 2021:

Chocolate products sales decreased during the six months ended June 30, 2022 compared to the six months ended June 30, 2021 due primarily to increased supply chain costs and a decrease in marketing and advertising.

Merchant cash advances sales decreased during the six months ended June 30, 2022 compared to the six months ended June 30, 2021 due to the Company focusing upon and dedicating resources to the chocolate producing division of the Company.

Products cost of sales for the six months ended June 30, 2022 and 2021 were as follows:

The decrease in cost of product sales in June 30, 2022 as compared to June 30, 2021 was due to a decrease in product sales.

Legal fees for the six months ended June 30, 2022 was $29,098 compared to $3,096 for the six months ended June 30, 2021. This increase in legal fees was due to increased legal rates and legal consultations for potential deals that were passed on.

General and administrative expenses for the six months ended June 30, 2022 was $739,978 compared to $933,810 for the six months ended June 30, 2021. The decrease in general and administrative expenses was primarily due to decreased costs associated with compensation expenses, and consulting and accounting fees.

Provision for merchant cash advances for the ~~three~~six months ended ~~March 31,~~June 30, 2022 was ~~$(346)~~$36,799 compared to ~~$(137,498)~~$(144,338) for the ~~three~~six months ended ~~March 31,~~June 30, 2021. The ~~decrease~~increase in provision for merchant cash advances was due to the ~~collection~~Company updating its reserves to accurately reflect its current merchant cash advances positions.

Impairment of ~~a large balance in prior period from one MCA that~~assets expense for the six months ended June 30, 2022 was ~~previously fully reserved~~$92,736. The company has not realized cash flows sufficient to overcome an asset impairment and is, therefore, estimating an impairment of 50% of its asset carrying value. There was no impairment expense for ~~due to COVID-19.~~the six months ended June 30, 2021.

	Three Months Ended						Six Months Ended
	March 31,						June 30,
	2022			2021			2022			2021
Net cash used in operating activities	$	(117,139	)	$	(33,127	)	$	(237,313	)	$	(64,498	)
Net cash used in investing activities	$	-		$	-		$	-		$	(877	)
Net cash provided by financing activities	$	117,500		$	24,464		$	248,000		$	207,261

Our primary uses of cash from our operating activities include payments for compensation and related costs and other general corporate expenditures.

Net cash used in operating activities increased from the ~~three~~six months ended ~~March 31,~~June 30, 2021 to the ~~three~~six months ended ~~March 31,~~June 30, 2022 primarily due to the net effect of a decrease in cash received from a decrease in revenues and cash paid for cost of revenues and operating expenses, changes in operating assets and liabilities, decrease in stock compensation, increase in accumulative catch up adjustment and impairment of assets, and change in merchant allowance.

There was no investing activities for the ~~three~~six months ended ~~March 31, 2022 and 2021.~~June 30, 2022.

Cash provided by financing activities consists of proceeds from issuance of debt.

Net cash provided by financing activities increased from the ~~three~~six months ended ~~March 31,~~June 30, 2021 to the ~~three~~six months ended ~~March 31,~~June 30, 2022 primarily due to ~~an increase of proceeds from issuance of loans and~~ a decrease ofin repayment of ~~loans..~~loans.

The Company’s unaudited condensed consolidated financial statements are prepared using generally accepted accounting principles in the United States of America applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business.

The Company has not yet established an ongoing source of revenues sufficient to cover its operating costs and allow it to continue as a going concern. The ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it becomes profitable. If the Company is unable to obtain adequate capital, it could be forced to cease operations.

In order to continue as a going concern, the Company will need, among other things, additional capital resources. As of ~~March 31,~~June 30, 2022, the Company had approximately ~~$1,367,000~~$1,364,000 in third-party short-term debt and approximately ~~$42,000~~$3,100 in associated debt discount and approximately ~~$578,000~~$708,000 in related-party short-term debt and ~~approximately $3,800~~$0 in associated debt discount that is due within the next twelve months. Management’s plan is to increase revenue, obtain such resources for the Company by obtaining capital from management and significant shareholders sufficient to meet its operating expenses and seeking equity and/or debt financing. However, neither any members of management nor any significant shareholders are currently committed to invest funds with us and; therefore, we cannot provide any assurances that the Company will be successful in accomplishing any of its plans.

The Company does not have sufficient cash flow for the next twelve months from the issuance of these unaudited condensed consolidated financial statements. The ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plans described in the preceding paragraph and eventually secure other sources of financing and attain profitable operations. The accompanying unaudited condensed consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

As of ~~March 31,~~June, 2022, the Company's concentrations for receivables from merchant cash advances as well as income from merchant cash advances were not significant to warrant concentration risk.

Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting is defined in Rule 13a-15(f) or 15d-15(f) promulgated under the Securities Exchange Act of 1934 as a process designed by, or under the supervision of, the Company’s principal executive officer and principal financial officer and effected by our board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) and includes those policies and procedures that:

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. All internal control systems, no matter how well designed, have inherent limitations. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation. Because of the inherent limitations of internal control, there is a risk that material misstatements may not be prevented or detected on a timely basis by internal control over financial reporting. However, these inherent limitations are known features of the financial reporting process. Therefore, it is possible to design into the process safeguards to reduce, though not eliminate, this risk.

The Company’s management, including the chief executive officer and chief financial officer, do not expect that its disclosure controls or internal controls will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. In addition, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake.

As of ~~March 31,~~June 30, 2022, management has not completed an effective assessment of the Company’s internal controls over financial reporting based on the 2013 Committee of Sponsoring Organizations (COSO) framework. Management has concluded that, during the period covered by this report, our internal controls and procedures were not effective to detect the inappropriate application of U.S. GAAP. Management identified the following material weaknesses set forth below in our internal control over financial reporting.

There were no changes in our internal control over financial reporting that occurred during the quarter ended ~~March 31,~~June 30, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

As of ~~March 31,~~June 30, 2022, we were not a party to any legal proceedings that could have a material adverse effect on the Company’s business, financial condition or operating results. Further, to the Company’s knowledge, no such proceedings have been threatened against the Company.

We are not obligated to disclose our risk factors in this report; however, information regarding our risk factors appears in various places in this Quarterly Report and in Part I, Item 1A, “Risk Factors” of our Annual Report on Form 10-K for the year ended December 31, 2021. Except as described below, there have been no material changes from the risk factors previously disclosed in such Annual Report on Form 10-K.

The Company issued 60,000 shares of the Company’s common stock during the ~~three~~six months ended ~~March 31,~~June 30, 2022. All of these shares were exempt pursuant to Section 4(1) as they were issued privately without any advertising or finders/brokers fees paid to third parties.

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		Pages

PART I. FINANCIAL INFORMATION

Item 1.	Condensed Consolidated Financial Statements (Unaudited)	3

	Condensed Consolidated Balance Sheets at ~~March 31,~~June 30, 2022 and December 31, 2021	3

	Condensed Consolidated Statements of Operations for the Three and Six Months ended ~~March 31,~~June 30, 2022 and 2021	4

	Condensed Consolidated Statements of Changes in Deficit for the Three and Six Months ended ~~March 31,~~June 30, 2022 and 2021	5

	Condensed Consolidated Statements of Cash Flows for the ~~Three~~Six Months ended ~~March 31,~~June 30, 2022 and 2021	6

	Notes to Condensed Consolidated Financial Statements	7

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	19

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	2225

Item 4.	Controls and Procedures	2326

PART II OTHER INFORMATION

Item 1.	Legal Proceedings	2427

Item 1A.	Risk Factors	2427

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	2427

Item 3.	Defaults Upon Senior Securities	2427

Item 4.	Mine Safety Disclosures	2427

Item 5.	Other Information	2427

Item 6.	Exhibits	2528

SIGNATURES		2629

					Associated equity instruments recorded as debt discount
			Original	New	Common		Fair Value of Common				Fair Value of
		Interest	Maturity	Maturity	Shares		Shares		Warrants		Warrants		June 30,		December 31,
		Rate	Date	Date**	issued		issued		issued		issued		2022		2021
	1	12%*	4/17/22	10/31/22									$	100,000	$	100,000
During the six months ended June 30, 2022						-		-		-		-
During the six months ended June 30, 2021						-		-		-		-
	2	0%*	4/24/22	8/31/22										179,813		179,813
During the six months ended June 30, 2022						-		-		-		-
During the six months ended June 30, 2021						-		-		-		-
	3	12%*	4/16/22	8/30/22										150,000		150,000
During the six months ended June 30, 2022						-		-		-		-
During the six months ended June 30, 2021						130,000		26,500		100,000		20,200
	4	0%*	9/15/22											500		500
During the six months ended June 30, 2022						-		-		-		-
During the six months ended June 30, 2021						-		-		-		-
	5	0%*	5/30/22	12/31/22										278,000		60,000
During the six months ended June 30, 2022						-		-		-		-
During the six months ended June 30, 2021						-		-		-		-
	6	0%*	Loans fully repaid in 2021									-		-		-
During the six months ended June 30, 2022						-		-		-		-
During the six months ended June 30, 2021						60,000		12,660		-		-
Unamortized debt discount														-		(19,304	)
Total													$	708,313	$	471,009

		Interest Rate	Original Maturity Date	New Maturity Date **	Common Shares issued		Fair Value of Common Shares issued		Warrants issued		Fair Value of Warrants issued		March 31, 2022			December 31, 2021
	1	12%*	4/17/2022	10/31/2022									$	100,000		$	100,000
During the three months ended March 31, 2022						-		-		-		-
During the three months ended March 31, 2021						-		-		-		-
	2	0%*	4/24/2022	8/31/2022										179,813			179,813
During the three months ended March 31, 2022						-		-		-		-
During the three months ended March 31, 2021						-		-		-		-
	3	12%*	4/16/2022	8/20/2022										150,000			150,000
During the three months ended March 31, 2022						-		-		-		-
During the three months ended March 31, 2021						80,000		16,000		-		-
	4	0%*	9/15/2022											500			500
During the three months ended March 31, 2022						-		-		-		-
During the three months ended March 31, 2021						-		-		-		-
	5	0%*	5/30/2022											147,500			60,000
During the three months ended March 31, 2022						-		-		-		-
During the three months ended March 31, 2021						-		-		-		-
	6	0%*	Loans fully repaid in 2021
During the three months ended March 31, 2022						-		-		-		-
During the three months ended March 31, 2021						60,000		12,660		-		-
	Unamortized debt discount													(3,792	)		(19,304	)
	Total												$	574,021		$	471,009

		Interest Rate	Original Maturity Date	New Maturity Date ****	Common Shares issued			Fair Value of Common Shares issued		Warrants issued		Fair Value of Warrants issued		March 31, 2022			December 31, 2021
	1	12%*	4/16/2022	8/31/2022										$	50,000		$	50,000
During the three months ended March 31, 2022						-			-		-		-
During the three months ended March 31, 2021						-			-		-		-
	2	12%*	4/22/2022	11/30/2022											18,000			18,000
During the three months ended March 31, 2022						-			-		-		-
During the three months ended March 31, 2021						18,000			4,680		-		-
	3	12%*	6/30/2022												250,000			250,000
During the three months ended March 31, 2022						-			-		125,000		28,088
During the three months ended March 31, 2021						-			-		-		-
	4	12%*	4/16/2022												410,000			410,000
During the three months ended March 31, 2022						-			-		-		-
During the three months ended March 31, 2021						-			-		-		-
	5	12%*	4/16/2022												140,000			140,000
During the three months ended March 31, 2022						-			-		-		-
During the three months ended March 31, 2021						-			-		-		-
	6	12%*	4/30/2022												200,000			200,000
During the three months ended March 31, 2022						-			-		-		-
During the three months ended March 31, 2021						-			-		-		-
	7	12%*	7/31/2022												60,000			60,000
During the three months ended March 31, 2022						60,000			12,600		-		-
During the three months ended March 31, 2021						-			-		-		-
	8	12%*	7/29/2022												96,000			96,000
During the three months ended March 31, 2022						-			-		-		-
During the three months ended March 31, 2021						-			-		-		-
	9	3.75% **	6/25/2050												150,000			150,000
During the three months ended March 31, 2022						-			-		-		-
During the three months ended March 31, 2021						-			-		-		-
	10	12.5%*	12/17/2022												3,600			3,600
During the three months ended March 31, 2022						-	��		-		-		-
During the three months ended March 31, 2021						-			-		-		-
	11	0%*	9/19/2022												16,500			16,500
During the three months ended March 31, 2022						-			-		-		-
During the three months ended March 31, 2021						-			-		-		-
	12	0%*	4/16/2022	8/31/2022											50,000			50,000
During the three months ended March 31, 2022						-			-		-		-
During the three months ended March 31, 2021						-			-		-		-
	13	0% ***	4/16/2022	5/31/2022											30,000			30,000
During the three months ended March 31, 2022						-			-		-		-
During the three months ended March 31, 2021						-			-		-		-
	14	0%*	4/16/2022	5/31/2022											13,000			13,000
During the three months ended March 31, 2022						-			-		-		-
During the three months ended March 31, 2021						-			-		-		-
	15	0% ***	5/30/2022												30,000			0
During the three months ended March 31, 2022						-			-		-		-
During the three months ended March 31, 2021						-			-		-		-
	Unamortized debt discount														(41,856	)		(48,514	)
	Total														1,475,244			1,438,586
	Less: short term loans, net														1,325,244			1,288,586
	Total long-term loans, net													$	150,000		$	150,000

No. of Warrants		Milestone
100,000		Acceptance by the Company of a full go-to market strategy for the ~~Company's~~Company’s products. This milestone has been achieved.
100,000		Acceptance by the Company of a social marketing platform and PR strategy and onboarding of such.
300,000/500,000		300,000 for each multi outlet (“MULO”) retailer that is onboarded -– regardless of store count carrying the product; and 500,000, if the onboarded MULO is a national chain.
300,000		Deliverance of full due diligence package for each potential acquisition for which the Company requests the consultant perform due diligence
500,000		Upon the closing of any acquisition which the consultant brought to the Company and provided due diligence.
500,000		Additional compensation in board seat agreement.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated Filer	☒	Smaller reporting company	☒
		Emerging growth company	☐

First Foods Group, Inc. and Subsidiary
Condensed Consolidated Balance Sheets

		Interest Rate	Original Maturity Date		New Maturity Date ********	Common Shares issued		Fair Value of Common Shares issued		Warrants issued		Fair Value of Warrants issued		June 30, 2022			December 31, 2021
	1	12%*	4/16/2022		8/31/2022									$	50,000		$	50,000
During the six months ended June 30, 2022							-		-		-		-
During the six months ended June 30, 2021							-		-		-		-
	2	12%*	4/22/2022		11/30/2022										18,000			18,000
During the six months ended June 30, 2022							-		-		-		-
During the six months ended June 30, 2021							18,000		4,680		-		-
	3	12%*	6/30/2022		12/31/2022										250,000			250,000
During the six months ended June 30, 2022							-		-		125,000		28,088
During the six months ended June 30, 2021							-		-		-		-
	4	12%*	4/16/2022		12/31/2022										410,000			410,000
During the six months ended June 30, 2022							-		-		-		-
During the six months ended June 30, 2021							-		-		-		-
	5	12%*	4/16/2022		12/31/2022										140,000			140,000
During the six months ended June 30, 2022							-		-		-		-
During the six months ended June 30, 2021							-		-		-		-
	6	12%*	4/30/2022		12/31/2022										200,000			200,000
During the six months ended June 30, 2022							-		-		-		-
During the six months ended June 30, 2021							-		-		-		-
	7	12%*	7/31/2022		12/31/2022										60,000			60,000
During the six months ended June 30, 2022							60,000		12,600		-		-
During the six months ended June 30, 2021							-		-		-		-
	8	12%*	7/29/2022	��	12/31/2022										96,000			96,000
During the six months ended June 30, 2022							-		-		-		-
During the six months ended June 30, 2021							-		-		-		-
	9	3.75% **	6/25/2050												150,000			150,000
During the six months ended June 30, 2022							-		-		-		-
During the six months ended June 30, 2021							-		-		-		-
	10	12.5%*	12/17/2022												3,600			3,600
During the six months ended June 30, 2022							-		-		-		-
During the six months ended June 30, 2021							-		-		-		-
	11	0%*	9/19/2022												16,500			16,500
During the six months ended June 30, 2022							-		-		-		-
During the six months ended June 30, 2021							-		-		-		-
	12	0%*	4/16/2022		8/31/2022										50,000			50,000
During the six months ended June 30, 2022							-		-		-		-
During the six months ended June 30, 2021							-		-		-		-
	13	0% ***	4/16/2022		8/31/2022										30,000			30,000
During the six months ended June 30, 2022							-		-		-		-
During the six months ended June 30, 2021							-		-		-		-
	14	0%*	4/16/2022		8/31/2022										13,000			13,000
During the six months ended June 30, 2022							-		-		-		-
During the six months ended June 30, 2021							-		-		-		-
	15	0% ***	5/30/2022		8/31/2022										30,000			0
During the six months ended June 30, 2022							-		-		-		-
During the six months ended June 30, 2021							-		-		-		-
	Unamortized debt discount														(3,112	)		(48,514	)
	Total														1,513,988			1,438,586
	Less: short term loans, net														1,363,988			1,288,586
	Total long-term loans, net													$	150,000		$	150,000

	·	A $6,000 per month advance of Holy Cacao equity distribution will be awarded every month Holy Cacao earns a net profit over a period of twenty-four (24) consecutive months following the initial product launch and production sale.

	·	300,000 warrants for shares of the Company’s common stock will be awarded after each of two consecutive twelve (12) month periods in which Holy Cacao earns a net profit from gross annual product sales of at least $1M. Each of the two 300,000 warrant awards will vest equally over a twelve (12) month period. As of ~~March 31,~~June 30, 2022, these targets have not been achieved and the Company has determined it is not probable of being met at this time, as such no compensation expense has been recorded.

·	statements concerning the potential benefits that First Foods Group, Inc. (“First Foods”, “we”, “our”, “us”, the “Company”, or “management”) may experience from its business activities and certain transactions it contemplates or has completed; and

·	statements of First Foods’ expectations, beliefs, future plans and strategies, anticipated developments and other matters that are not historical facts. These statements may be made expressly in this Form 10-Q. You can find many of these statements by looking for words such as “believes,” “expects,” “anticipates,” “plans”, “estimates,” “opines,” or similar expressions used in this Form 10-Q. These forward-looking statements are subject to numerous assumptions, risks and uncertainties that may cause First Foods’ actual results to be materially different from any future results expressed or implied by First Foods in those statements. The most important facts that could prevent First Foods from achieving its stated goals include, but are not limited to, the following:

	(a)	volatility or decline of First Foods’ stock price;
	(b)	potential fluctuation of quarterly results;
	(c)	include failure of First Foods to earn significant revenues or profits;
	(d)	inadequate capital to continue or expand its business, and inability to raise additional capital or financing to implement its business plans;
	(e)	decline in demand for First Foods’ products and services;
	(f)	rapid adverse changes in markets; due to, among other things, international conflicts, terrorism, environmental issues, world and national health issues, and inflation;
	(g)	litigation with or legal claims and allegations by outside parties against First Foods, including but not limited to challenges to First Foods’ intellectual property rights;
	(h)	reliance on proprietary merchant advance credit models, which involve the use of qualitative factors that are inherently judgmental and which could result in merchant defaults; and
	(i)	new regulations impacting the business.

3.1		Articles of Incorporation of the Registrant (1)
3.2		By-laws of the Registrant (1)
31.1		Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2		Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1		Certification of Chief Executive Officer pursuant to 18 U.S.C. 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002
32.2		Certification of Chief Financial Officer pursuant to 18 U.S.C. 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002
101.INS		Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).
101.SCH		Inline XBRL Taxonomy Extension Schema ~~Document~~Document.
101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase ~~Document~~Document.
101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase ~~Document~~Document.
101.LAB		Inline XBRL Taxonomy Extension ~~Label~~Labels Linkbase ~~Document~~Document.
101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase ~~Document~~Document.
104		Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).

By:	/s/ Harold Kestenbaum	Dated: ~~May 23,~~August 22, 2022
	Harold Kestenbaum,
	Chairman of the Board and
	Interim Chief Executive Officer

By:	/s/ Mark J. Keeley	Dated: ~~May 23,~~August 22, 2022
	Mark J. Keeley,
	Chief Financial Officer